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Abstract
Purpose—Accurate target definition is considered essential for sophisticated, image-guided
radiation therapy; however, relatively little information has been reported that measures our ability
to identify the precise shape of targets accurately. We decided to assess the manner in which eight
“experts” interpreted the size and shape of tumors based on “real life” contrast-enhanced CT scans.
Methods and Materials—Four neuroradiologists and four radiation oncologists (the authors) with
considerable experience and presumed expertise in treating head and neck tumors independently
contoured, slice-by-slice, his/her interpretation of the precise gross tumor volume (GTV) on each of
twenty sets of CT scans taken from twenty patients who previously were enrolled in Radiation
Therapy Oncology Group protocol 9111.
Results—The average proportion of overlap (i.e., the degree of agreement) was 0.532 (95%
confidence interval 0.457 to 0.606). There was a slight tendency for the proportion of overlap to
increase with increasing average GTV.
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Conclusions—Our work suggests that estimation of tumor shape currently is imprecise, even for
experienced physicians. In consequence, there appears to be a practical limit to the current trend of
smaller fields and tighter margins.
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Introduction
Reduced to its simplest elements, the goal of radiation therapy is to irradiate all malignant cells
while avoiding all normal ones. This suggests that all malignant cells can be identified and that
technology can deliver radiation exclusively to the targeted cells. In recent years the technology
to deliver radiation therapy has advanced substantially and the patterns of dose distribution
produced by intensity modulated radiation therapy (IMRT) can now shape dose clouds to
conform to targets far more closely than ever before, while relatively sparing normal tissues.
Computerized tomography, magnetic resonance imaging and positron emission tomography
are being used increasingly to help define targets for more sophisticated forms of radiation
therapy. But, how well do we, as clinicians, interpret these modalities and how well do our
targets represent reality?
The American College of Radiology Imaging Network (ACRIN) protocol 6658 was designed
to calculate the interobserver variability of gross tumor volume (GTV) determined by different
physicians for patients who had squamous cell carcinoma of the supraglottic larynx
(SGSCCA).(1) Eight experienced physicians from different institutions (four neuroradiologists
with considerable experience and presumed expertise in delineating head and neck tumors and
four radiation oncologists with considerable experience and presumed expertise in treating
head and neck tumors) independently contoured, slice-by-slice, his/her interpretation of the
precise GTV on each of twenty sets of CT scans taken from twenty patients who previously
were enrolled in Radiation Therapy Oncology Group (RTOG) protocol 91-11.(2) We have
already reported the outcome (1) of these investigations with respect to primary tumor volumes
and essentially demonstrated that GTV measurements are reliably and reproducibly measured
by neuroradiologists and radiation oncologists who were experienced in the interpretation of
CT scans of the extracranial head and neck in patients with SGSCCA. Consequently, the
likelihood of control of disease by radiation therapy alone, based on the volume of disease, is
consistent from experienced physician to experienced physician.(3) However, as part of this
process, we noticed that the precise shape of the cross-sectional areas deemed to represent
tumor on individual slices of each set of scans was not uniformly congruent among the
physicians. As the sum of these slices in a given set represents the perceived shape of the tumor,
we decided to investigate precisely how similar the shapes of the tumors that each of the eight
physicians contoured were to each other. The assessment of shape is critical for treatment
planning and therapy in Radiation Oncology, particularly when IMRT is used. This report
details our findings with respect to these “real life” examples of three-dimensional tumor shape
assessment by experienced physicians.
Material and Methods
ACRIN protocol 6658 was based on data from a subset of eligible patients with squamous cell
carcinoma of the supraglottic larynx entered into Radiation Therapy Oncology Group (RTOG)
protocol 91-11 who had a CT scan and who had been randomized to the “definitive RT only”
arm. Informed consent for RTOG 91-11 included consent for subsequent research as long as
patient confidentiality was maintained and the use of the images from RTOG 91-11 occurred
only after the ACRIN 6658 was approved by the National Cancer Institute Cancer Therapy
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Evaluation Program, by the Institutional Review Board (IRB) of the American College of
Radiology, and by each local IRB of participating institutions.
Details of the procedures for delineation of slice-by-slice estimates of tumor involvement have
previously been published.(1) Subsequently, the first author (JSC) outlined the areas of
concordance (and therefore non-concordance) on every CT slice, for every pair of readers, for
every case. Following the contouring of areas of concordance on each CT slice, the volumes
of concordance (overlap) and non-concordance for each reader pair for each case were
automatically calculated by the proprietary software package (BIT Display 07x00) which
automatically accounted for differences in slice thickness, table spacing, and field of view to
ensure accurate measurements.
In the absence of surgical resection and histologic measurement, the precise “true” tumor shape
and volume is unknown. Typical, simple descriptive statistical analyses comparing our findings
to a “true standard” therefore could not be applied. In addition, because the tumor itself typically
occupies only a small portion of the area of each CT slice (or in the aggregate volumes), the
area (or volumes) not included in the contours drawn by readers would dominate any statistic
that simply measured spatial agreement. We therefore chose to quantify the degree of
concordance by calculating the proportion of overlap between pairs of readers, i.e., the
overlapping volume divided by the sum of the overlapping and non-overlapping volumes. To
estimate any potential influence of the specialty training of the readers, we not only estimated
average proportions of overlap for all readers, we also specifically compared the outcome
within types of reader pairs (i.e., 2 diagnostic radiologists, 2 radiation oncologists, one of each),
along with standard errors of those estimates.
Statistical inference is further complicated because the proportion of overlap for a pair of
readers in any case is correlated with all other proportions of overlap for that case, and all other
proportions of overlap involving either or both of those readers. For example, if two readers
have different contouring tendencies (such as one reader contouring with relatively tight
margins routinely and the other contouring with relatively large margins routinely) their
estimates of shape and volume would be consistently affected. To address this, we used a
regression model for proportion of overlap that incorporated a fixed mean proportion of overlap
and random effects for cases, readers, and their interactions. Because we wanted to learn if the
estimation of shape was influenced by the size of the tumor, we compared the observed
correlations of overlap by primary tumor volumes. Since the “true” primary tumor volumes
could not be measured, we estimated the “true” volume for each case as the average of all
volumes estimated by all readers, mindful that this method, by itself, creates a relationship
between the proportion of overlap and the estimated primary tumor volume (To compensate
for this, we used a permutation distribution of the correlation under the null hypothesis of no
relationship).
Results
The proportion of overlap was computed for 546 reader pairs (it could not be computed for the
remaining 14 reader pairs because contours from 2 cases were missing for 1 reader due to a
computer error resulting in accidental overwriting of the files). Figures 1 and 2 demonstrate
examples of relatively high and low concordance of the shapes outlined on one slice of one set
of scans by two readers. Overall, the average proportion of overlap was 0.532 (range: 0.000 to
0.818), with 95% confidence interval for average proportion of overlap from 0.457 to 0.606.
Figure 3 shows the relationship of proportion of overlap to the average of the tumor volumes
across the eight study readers. There is a slight tendency for proportion of overlap to increase
with increased average GTV. The correlation between values of proportion of overlap and
average tumor volume is 0.490 (p-value < 0.0002).
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On average, proportion of overlap was slightly lower when one or both members of the reader
pair were radiation oncologists (averages of 0.516 and 0.526, respectively, with ranges from
0.000 to 0.816 and 0.812, respectively) than when both members of the reader pair were
radiologists (average = 0.580, range: 0.158 to 0.818). However, the standard error of the
average proportion of overlap among reader pairs when both readers were radiologists was
0.048, compared with 0.041 when one reader was a radiologist and the other a radiation
oncologist and 0.037 when both readers were radiation oncologists. Corresponding 95%
confidence intervals for average proportion of overlap were: 0.454 to 0.598 when both readers
were radiation oncologists, 0.485 to 0.675 when both readers were radiologists, and 0.436 to
0.597 when the reader pair was mixed.
Discussion
In a 2003 manuscript (6) titled “Image Guidance For Precise Conformal Radiotherapy”,
Mackie et al. wrote, “Image guidance is beginning to be the fundamental basis for radiotherapy
planning, delivery, and verification.” A guidance document on delivery, treatment planning,
and clinical implementation of IMRT from the American Association of Physicists in Medicine
(7) states, “With inverse planning, the physician designates targets instead of designing fields,
so careful and accurate contouring is essential.” Both statements imply that currently obtainable
images represent accurate depictions of the extent of the tumor and that physicians are capable
of accurately translating these images into three-dimensional targets. This study was designed
to test the latter hypothesis.
Two overlapping issues need to be discussed in this context. The first is the reproducibility of
tumor volume measurements. We previously have reported high levels of agreement among
the authors in the determination of the volumes of tumor as part of this ACRIN study (1). This
is reassuring for decisions concerning the suitability of radiation therapy as a treatment
modality for a given tumor in light of the data suggesting quasi-thresholds of volume above
which radiation therapy alone is not likely to eradicate disease.(3–5)
The second issue is shape, because volume and shape are only loosely related. For example, a
soccer ball and a football could be exactly the same volume and contain exactly the same
amount of air. Yet, the soccer ball and football will have substantially different shapes.
Similarly, two tumors can have identical volume, but substantially different shape. Volume
will influence the likelihood of control by radiation therapy at a given dose, but shape will
determine the placement of multileaf collimators/blocks, number of fields, adjacent normal
tissue that must be included in the treatment portals, etc.
Identification of targets, both those to be treated and those to be avoided has been the subject
of several recent reports.(8–13) However, these tend to focus on the ability of newer modalities
to detect tumors with greater sensitivity and specificity, presumably leading to better
recognition by physicians of targets. Hong et al.(14) have assessed the variability in IMRT
targets drawn from an unambiguous “virtual” tumor and reported what they termed
“remarkable variation” and “substantial variation.” Our work suggests that a relatively
overlooked, but important, parallel task in the process is to improve the agreement of “experts”
as to precisely what represents “tumor” when looking at exactly the same images drawn from
real life cases.
Our work examines the precise three-dimensional shapes that eight experienced physicians
derived from contrast enhanced CT-images of 20 real-life supraglottic carcinomas. Although
the speed and resolution of CT scanners appears to be getting better and better over time and
our group of physicians might have performed differently if all of the images were obtained
from a 2006-vintage top-of-the-line scanner and were technically perfect, our work probably
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represents the real world experience far better. It suggests that on average each pair of reviewers
agreed on approximately one-half (53.17% +/− 3.80% standard dev.) of each tumor’s exact
shape. Some differences in the average degree of concordance are apparent between physicians
grouped by their specialty (Radiologists vs. Radiation Oncologists vs. mixed), but no group
came close to perfect concordance.
Furthermore, the presence of overlapping volumes does not ensure correctness. As there is no
gold standard measure of a tumor’s shape while it remains in situ, we recognize that two
physicians can draw GTVs that have perfect overlap in the wrong location, or no overlap with
each including only part of the tumor, and we could not measure the difference from “absolute
truth”.
The implications of our work suggest that estimation of tumor shape currently is less than a
precise science. When the limitations of available technology dictated large parallel opposed
or 3-field techniques for the management of head and neck tumors, the precise estimation of
a tumor’s shape was not critical. But, today’s image-guided, intensity modulated technology
imposes an obligation upon the profession; we must be critically aware of our limitations lest
we confuse the precision of image guidance and the conformality of IMRT with accuracy of
targeting tumors. How we train ourselves to practice and how we accredit facilities for IMRT
protocol participation at present still appear to require some volume to be added to GTVs to
compensate for our inability to know the precise shape of the intended target. Although some
tumors may be easier to describe (our maximum observed concordance between two observers
was 81.8%), in our worst case there was no agreement between two observers. Consequently,
there appears to be a practical limit to the current trend of smaller and smaller fields with tighter
and tighter margins that may ultimately influence the success and applicability of image guided,
intensity modulated radiation therapy techniques.
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Example of Relatively Good Concordance of Shape Estimates by Two Physicians.
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Example of Relatively Poor Concordance of Shape Estimates by Two Physicians.
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Relationship of proportion of overlap to mean PTV.
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